It shall be completely obtained by sufferers with untreated a number of myeloma, over 65 years of age, unfit to obtain high-dose chemotherapy. Women with childbearing potential can solely be handled if a collection of necessities are met. Its prescription and dishing out is topic to a Controlled Access System.
On February 2, ‘Thalidomide Accord 50 mg arduous capsules EFG’ will start to be marketed in Spain. The controversial drug, created in 1953 by the German pharmaceutical firm Chemie Grünenthal, and which combated morning illness, was accountable for malformations (phocomelia) in additional than 10,000 infants born till it was banned in 1961 by most international locations.
Now, the Spanish Agency for Medicines and Health Products (AEMPS) proclaims that thalidomide shall be equipped together with melphalan and prednisone for first-line therapy completely in sufferers with untreated a number of myeloma, aged 65 years or unfit for chemotherapy at excessive doses. It is taken into account an ‘orphan drug’ used for uncommon ailments.
Through a press release, the AEMPS, beneath the Ministry of Health, warns that, because of the threat of manufacturing congenital malformations, using thalidomide “is contraindicated in pregnant ladies.”
Aware of the dangers for pregnant ladies, the European authorities have established a collection of necessities for its prescription and dishing out. All of them are included in a Pregnancy Prevention Plan (PPE) and a Controlled Access System whose goal is to keep away from any publicity to thalidomide in pregnant ladies.
Peter Longstaff, sufferer of thalidomide, and with out arms, paints with the precise foot. In Kelling (Norfolk, United Kingdom)Red Williams
In reality, these sufferers who’re going to obtain it should fill out a threat consciousness kind, which is obtainable within the CIMA part of the AEMPS web site. Said doc should be accomplished and signed by each the medical skilled and the affected person, and can subsequently be despatched to the Hospital Pharmacy Service to be able to request the availability of thalidomide via the Controlled Access System established by the AEMPS.
These necessities will apply to any medication available on the market that accommodates this lively ingredient.
Requirements for administration in ladies
Women with childbearing potential can solely be handled if the next is true:
Use of efficient contraceptive measures with out interruption as stipulated within the knowledge sheet Performance of being pregnant assessments earlier than beginning therapy, each 4 weeks throughout therapy and 4 weeks after the tip of therapy Understanding the danger of great congenital malformations for the fetus in case of being pregnant, about different critical dangers of therapy and the necessity to seek the advice of your physician shortly should you assume chances are you’ll be pregnant. Requirements referring to male sufferersIn male sufferers, the opportunity of threat of great congenital malformations shall be reported if they’ve sexual activity with a pregnant or doubtlessly pregnant girl, as thalidomide is excreted via semen, so it’s needed to make use of a condom throughout all through the therapy (together with durations of interruption of administration) and for at the least seven days after completion. You should chorus from donating semen. The prescribing medical skilled should make sure that sufferers are conscious of and conform to adjust to the circumstances of this system Risk Awareness Form
The request for therapy with thalidomide shall be made via the AEMPS Medications in Special Situations (MSE) utility, the place a selected kind has been arrange with the necessities of the Controlled Access System. In this fashion, when making an preliminary request for therapy, the age, therapeutic indication, and sort of affected person (girl with/with out gestation capability or man) should be supplied; the affected person threat consciousness kind accomplished and signed by each the medical skilled (who ensures that they’ve defined the small print of this therapy and its related dangers), and by the affected person (who confirms that they perceive and conform to adjust to the necessities of the PPE, giving their consent to begin the therapy).